Prospective, Phase 3, Randomized, Multi-center, Double-blind, Double-dummy Study of Efficacy, Tolerability & Safety of Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Treatment of cUTI in Adults
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Sulopenem (Primary) ; Sulopenem (Primary) ; Amoxicillin/clavulanic acid; Ciprofloxacin; Ertapenem; Probenecid
- Indications Pyelonephritis; Urinary tract infections
- Focus Registrational; Therapeutic Use
- Sponsors Iterum Therapeutics
- 27 Jun 2018 Planned End Date changed from 1 Oct 2019 to 1 Dec 2019.
- 27 Jun 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Oct 2019.
- 25 Nov 2017 Status changed from planning to not yet recruiting.